Literature DB >> 229827

Uridine kinase activities in developing, adult and neoplastic rat tissues.

A Herzfeld, S M Raper.   

Abstract

Uridine kinase activities were found chiefly in the soluble fractions of rat tissues. In normal adults the activities ranged from 13 munits/g in skeletal muscle to 178 munits/g in colon. Enzyme activities in several rat neoplasms were significantly higher (e.g. in a fibrosarcoma, mammary carcinoma, renal carcinoma, pancreatic carcinoma and lymphocytic lymphoma, but not in a fast-growing Morris hepatoma). The activities were not related to tumour growth rates or sizes. In normal foetal liver, lung, brain, heart and kidney, uridine kinase concentrations equalled or exceeded those in the adult homologous tissue, but maximal activities in liver were reached 3--5 days post partum. In suckling rats the intestinal activity decreased substantially immediately after birth and normally did not rise again until late in the third postnatal week. Premature upsurges could be evoked by an injection of cortisol or by starvation of the pups overnight. Pancreatic activity was absent from 1-day-old rats, and only about 5% of the adult activity was reached by day 20; adult activities were attained rapidly after weaning. In pancreas, precocious formation or uridine kinase was elicited by overnight starvation of 2-week-old rats.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 229827      PMCID: PMC1161411          DOI: 10.1042/bj1820771

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Pyrimidine metabolism. IV. A comparison of normal and regenerating rat liver.

Authors:  E S CANELLAKIS; J J JAFFE; R MANTSAVINOS; J S KRAKOW
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  Enzymes of uracil metabolism in the Ehrlich ascites tumour and mammalian liver.

Authors:  P REICHARD; O SKOLD
Journal:  Biochim Biophys Acta       Date:  1958-05

3.  Transplantable pancreatic carcinoma of the rat.

Authors:  J K Reddy; M S Rao
Journal:  Science       Date:  1977-10-07       Impact factor: 47.728

4.  Aspartate aminotransferase in fat tissues: changes with growth and hormones.

Authors:  A Herzfeld; O Greengard
Journal:  Biochim Biophys Acta       Date:  1971-04-20

5.  The dedifferentiated pattern of enzymes in livers of tumor-bearing rats.

Authors:  A Herzfeld; O Greengard
Journal:  Cancer Res       Date:  1972-09       Impact factor: 12.701

6.  Leucylnaphthylamidase in the small intestine of the mouse: normal development and influence of cortisone and antibiotics.

Authors:  F Moog; E H Birkenmeier; H S Glazier
Journal:  Dev Biol       Date:  1971-07       Impact factor: 3.582

7.  Glutamate dehydrogenase, alanine aminotransferase, thymidine kinase, and arginase in fetal and adult human and rat liver.

Authors:  A Herzfeld; V M Rosenoer; S M Raper
Journal:  Pediatr Res       Date:  1976-12       Impact factor: 3.756

8.  The effect of lymphoma and other neoplasms on hepatic and plasma enzymes of the host rat.

Authors:  A Herzfeld; O Greengard
Journal:  Cancer Res       Date:  1977-01       Impact factor: 12.701

9.  Uridine kinase activities in normal and neoplastic lymphoid cells.

Authors:  N Greenberg; D E Schumm; P E Hurtubise; T E Webb
Journal:  Cancer Res       Date:  1977-04       Impact factor: 12.701

10.  Tissue enzyme changes in parabiotic rats with subcutaneous lymphoma or fibrosarcoma.

Authors:  A Herzfeld; O Greengard; S Warren
Journal:  J Natl Cancer Inst       Date:  1978-04       Impact factor: 13.506

View more
  2 in total

1.  Postnatal ontogeny of uridine kinase in the cerebellum, hypothalamus, and cerebral cortex of the rat.

Authors:  M Litteria; C G Popoff
Journal:  Neurochem Res       Date:  1985-01       Impact factor: 3.996

Review 2.  Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases.

Authors:  An R Van Rompay; Magnus Johansson; Anna Karlsson
Journal:  Pharmacol Ther       Date:  2003-11       Impact factor: 12.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.